Phylogica: New potential for treating brain injury
Novel compound protects neural tissue, reduces inflammation
22-Feb-2011 -
Phylogica Ltd has successfully demonstrated preclinical proof of concept with a Phylomer peptide drug candidate for the treatment of traumatic brain injury.Using an internationally established preclinical model, a three-year collaborative study with the Australian Neuromuscular Research Institute ...
drug discovery
inflammation